TB-500 costs more per milligram than BPC-157 and requires higher weekly doses
Topical GHK-Cu human trials and systemic animal studies reveal an excellent tolerability profile with no documented toxicity
BPC-157 : Repairs microvascular injuries and accelerates healing in soft tissue wounds, supporting regeneration ( 13, 15 )
As such, the model was used to simulate how long it would take pharmacologically and toxicologically relevant concentrations of doxorubicin to yield a 70% reduction in GSH concentration, indicative of impaired cellular antioxidant defence, protein binding and cell death 19
Your health goals, lifestyle, and medical history all play a role in whether this therapy is the right fit
Medical history, labs, and medications are reviewed